Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study
Author(s) -
Jongwook Yu,
Soo Jung Park,
Hyung Wook Kim,
Yun Jeong Lim,
Jihye Park,
Jae Myung,
Byong Duk Ye,
Tae Oh Kim,
HyunSoo Kim,
Hyun Seok Lee,
Su Young Jung,
Youngdoe Kim,
Chang Hwan Choi
Publication year - 2021
Publication title -
gut and liver
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.331
H-Index - 44
eISSN - 2005-1212
pISSN - 1976-2283
DOI - 10.5009/gnl210335
Subject(s) - medicine , golimumab , ulcerative colitis , odds ratio , confidence interval , prospective cohort study , incidence (geometry) , adverse effect , logistic regression , postmarketing surveillance , rate ratio , gastroenterology , disease , adalimumab , physics , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom